SCHEMBL7450423

SCHEMBL7450423

N=C(CCC(=O)OC(=O)O)OC(=O)O.O=S1(=O)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57127 0.83 ALDH1A1 (0.35)
Ethylene Glycol SCHEMBL6129571 0.77 ALDH1A1 (0.31)
Cyclooctene SCHEMBL1299539 0.76
SCHEMBL3622179 0.69 ALDH1A1 (0.45)
SCHEMBL23042847 0.68
Benzamide SCHEMBL1205193 0.66 L3MBTL1 (0.50)
SCHEMBL43574 0.65 EGLN1 (0.43)
Bicarbonate SCHEMBL28089564 0.65 CA1 (0.36)
Bicarbonate SCHEMBL28089562 0.65 CA1 (0.36)
Propionic Acid SCHEMBL38658951 0.64 FFAR3 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0744948-A4 PROTEASE INHIBITORS LILLY CO ELI (US) 1997-06-11 EP disclosed
EP-0744948-A1 PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 1996-12-04 EP disclosed
WO-1995020962-A1 PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 1995-08-10 WO disclosed